Standardized guinea pig model for Q fever vaccine reactogenicity

Area of Science:

• Immunology and Vaccinology
• Veterinary Medicine
• Infectious Disease Research

Background:

• Whole cell Coxiella burnetii vaccines can cause hypersensitivity reactions in previously exposed individuals.
• Guinea pig models are used to evaluate vaccine reactogenicity, with intradermal skin testing common in humans.
• Existing models require refinement for accurate assessment of vaccine safety and potential adverse reactions.

Purpose of the Study:

• To refine a guinea pig model for evaluating vaccine reactogenicity and hypersensitivity.
• To compare different sensitization routes (intranasal vs. intraperitoneal) and challenge time points (21 vs. 42 days).
• To determine the optimal challenge route (intradermal vs. subcutaneous) and establish a standardized protocol.

Main Methods:

• Comparative study involving viable Coxiella burnetii sensitization via intranasal or intraperitoneal routes.
• Antigen challenge using the ruminant vaccine Coxevac at 21 and 42 days post-sensitization.
• Assessment of intradermal and subcutaneous challenge routes, with histopathological analysis and a developed scoring system.

Main Results:

• Intraperitoneal sensitization showed slightly larger gross reactions than intranasal sensitization.
• Reactions were more pronounced at 42 days compared to 21 days post-sensitization.
• Intradermal challenge was the optimal route for assessing reactogenicity; a group size of n=3 achieved 90% power.

Conclusions:

• The refined guinea pig model, using intranasal sensitization and intradermal challenge at 42 days, is effective for assessing vaccine reactogenicity.
• This standardized protocol enhances the ability to detect exposure-related hypersensitivity responses to Coxiella burnetii vaccines.
• The findings support the use of this model for future vaccine candidate evaluations, ensuring improved safety assessments.